Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 389

1.

Comparison of long-term prognostic value of N-terminal-proBNP and midregional-pro-adrenomedullin in patients with acute myocardial infarction.

Walter T, Brueckmann M, Lang S, Sauer T, Fiedler E, Papassotiriou J, Behnes M, Elmas E, Borggrefe M, Bertsch T.

Clin Lab. 2010;56(7-8):303-9.

PMID:
20857894
2.

Midregional pro-adrenomedullin in addition to b-type natriuretic peptides in the risk stratification of patients with acute dyspnea: an observational study.

Potocki M, Breidthardt T, Reichlin T, Morgenthaler NG, Bergmann A, Noveanu M, Schaub N, Uthoff H, Freidank H, Buser L, Bingisser R, Christ M, Mebazaa A, Mueller C.

Crit Care. 2009;13(4):R122. doi: 10.1186/cc7975. Epub 2009 Jul 23.

3.

Prognostic value of midregional pro-adrenomedullin in patients with acute myocardial infarction: the LAMP (Leicester Acute Myocardial Infarction Peptide) study.

Khan SQ, O'Brien RJ, Struck J, Quinn P, Morgenthaler N, Squire I, Davies J, Bergmann A, Ng LL.

J Am Coll Cardiol. 2007 Apr 10;49(14):1525-32. Epub 2007 Mar 26.

4.

Plasma N-terminal B-Type natriuretic peptide as an indicator of long-term survival after acute myocardial infarction: comparison with plasma midregional pro-atrial natriuretic peptide: the LAMP (Leicester Acute Myocardial Infarction Peptide) study.

Khan SQ, Dhillon O, Kelly D, Squire IB, Struck J, Quinn P, Morgenthaler NG, Bergmann A, Davies JE, Ng LL.

J Am Coll Cardiol. 2008 May 13;51(19):1857-64. doi: 10.1016/j.jacc.2008.01.041.

5.

Growth differentiation factor-15 as a prognostic marker in patients with acute myocardial infarction.

Khan SQ, Ng K, Dhillon O, Kelly D, Quinn P, Squire IB, Davies JE, Ng LL.

Eur Heart J. 2009 May;30(9):1057-65. doi: 10.1093/eurheartj/ehn600. Epub 2009 Jan 23.

6.

N-terminal pro B-type natriuretic peptide in the early evaluation of suspected acute myocardial infarction.

Haaf P, Balmelli C, Reichlin T, Twerenbold R, Reiter M, Meissner J, Schaub N, Stelzig C, Freese M, Paniz P, Meune C, Drexler B, Freidank H, Winkler K, Hochholzer W, Mueller C.

Am J Med. 2011 Aug;124(8):731-9. doi: 10.1016/j.amjmed.2011.02.035.

PMID:
21787902
7.

Midregional proadrenomedullin for prediction of cardiovascular events in coronary artery disease: results from the AtheroGene study.

Wild PS, Schnabel RB, Lubos E, Zeller T, Sinning CR, Keller T, Tzikas S, Lackner KJ, Peetz D, Rupprecht HJ, Bickel C, Morgenthaler NG, Papassotiriou J, Tiret L, Münzel T, Blankenberg S.

Clin Chem. 2012 Jan;58(1):226-36. doi: 10.1373/clinchem.2010.157842. Epub 2011 Nov 7.

8.

N-terminal pro-B-type natriuretic peptide is associated with adverse short-term clinical outcomes in patients with acute ST-elevation myocardial infarction underwent primary percutaneous coronary intervention.

Kwon TG, Bae JH, Jeong MH, Kim YJ, Hur SH, Seong IW, Cho MC, Seung KB, Jang YS, Park SJ; Korea Acute Myocardial Infarction Registry Investigators.

Int J Cardiol. 2009 Apr 3;133(2):173-8. doi: 10.1016/j.ijcard.2007.12.022. Epub 2008 Feb 20.

PMID:
18281115
9.

Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure.

von Haehling S, Jankowska EA, Morgenthaler NG, Vassanelli C, Zanolla L, Rozentryt P, Filippatos GS, Doehner W, Koehler F, Papassotiriou J, Kremastinos DT, Banasiak W, Struck J, Ponikowski P, Bergmann A, Anker SD.

J Am Coll Cardiol. 2007 Nov 13;50(20):1973-80. Epub 2007 Oct 29.

11.

Midregional pro-atrial natriuretic peptide is a useful indicator for the detection of impaired left ventricular function in patients with coronary artery disease.

Elmas E, Brueckmann M, Lang S, Kälsch T, Haghi D, Sueselbeck T, Dempfle CE, Borggrefe M.

Int J Cardiol. 2008 Aug 18;128(2):244-9. Epub 2007 Jul 27.

PMID:
17673312
12.

The interrelationship between preoperative anemia and N-terminal pro-B-type natriuretic peptide: the effect on predicting postoperative cardiac outcome in vascular surgery patients.

Goei D, Flu WJ, Hoeks SE, Galal W, Dunkelgrun M, Boersma E, Kuijper R, van Kuijk JP, Winkel TA, Schouten O, Bax JJ, Poldermans D.

Anesth Analg. 2009 Nov;109(5):1403-8. doi: 10.1213/ANE.0b013e3181b893dd.

PMID:
19843778
13.

Midregional proadrenomedullin (MR-proADM) in the risk stratification of patients with acute pulmonary embolism.

Pedowska-Włoszek J, Kostrubiec M, Kurnicka K, Ciurzynski M, Palczewski P, Pruszczyk P.

Thromb Res. 2013 Nov;132(5):506-10. doi: 10.1016/j.thromres.2013.08.008. Epub 2013 Aug 19.

PMID:
24060192
14.

Plasma N-terminal fragment of the prohormone B-type natriuretic peptide concentrations in relation to time to treatment and Thrombolysis in Myocardial Infarction (TIMI) flow: a substudy of the Assessment of the Safety and Efficacy of a New Treatment Strategy with Percutaneous Coronary Intervention (ASSENT IV-PCI) trial.

Jarai R, Huber K, Bogaerts K, Droogne W, Ezekowitz J, Granger CB, Sinnaeve PR, Ross AM, Zeymer U, Armstrong PW, Van de Werf FJ; ASSENT IV-PCI investigators.

Am Heart J. 2010 Jan;159(1):131-40. doi: 10.1016/j.ahj.2009.11.001.

PMID:
20102879
15.

Plasma N-terminal pro-B-type natriuretic peptide as long-term prognostic marker after major vascular surgery.

Feringa HH, Schouten O, Dunkelgrun M, Bax JJ, Boersma E, Elhendy A, de Jonge R, Karagiannis SE, Vidakovic R, Poldermans D.

Heart. 2007 Feb;93(2):226-31. Epub 2006 Aug 16.

16.

N-terminal pro-B-type natriuretic peptide levels for dynamic risk stratification of patients with acute coronary syndromes.

Heeschen C, Hamm CW, Mitrovic V, Lantelme NH, White HD; Platelet Receptor Inhibition in Ischemic Syndrome Management (PRISM) Investigators.

Circulation. 2004 Nov 16;110(20):3206-12. Epub 2004 Nov 8.

17.

Cardiotrophin-1 predicts death or heart failure following acute myocardial infarction.

Khan SQ, Kelly D, Quinn P, Davies JE, Ng LL.

J Card Fail. 2006 Oct;12(8):635-40.

PMID:
17045183
18.

Prognostic value of serum biomarkers in association with TIMI risk score for acute coronary syndromes.

Manenti ER, Bodanese LC, Camey SA, Polanczyk CA.

Clin Cardiol. 2006 Sep;29(9):405-10.

19.

A prospective cohort study of prognostic power of N-terminal probrain natriuretic peptide in patients with non-ST segment elevation acute coronary syndromes.

Ndrepepa G, Braun S, Mehilli J, Niemöller K, Schömig A, Kastrati A.

Clin Res Cardiol. 2007 Jan;96(1):30-7. Epub 2006 Oct 30.

PMID:
17066344
20.

Pro-B-type natriuretic peptide levels in acute decompensated heart failure.

Waldo SW, Beede J, Isakson S, Villard-Saussine S, Fareh J, Clopton P, Fitzgerald RL, Maisel AS.

J Am Coll Cardiol. 2008 May 13;51(19):1874-82. doi: 10.1016/j.jacc.2007.12.051.

Items per page

Supplemental Content

Write to the Help Desk